Autres langues Nipro Corporation

Actions

8086

JP3673600007

Equipement, fournitures et distribution médicale

Marché Fermé - Japan Exchange Autres places de cotation 08:30:00 17/07/2026			Varia. 5j.	Varia. 1 janv.
1 592,00 ^JPY	+0,76%		+2,94%	+7,79%

14/07	NIPRO CORPORATION : Jefferies & Co. est neutre	ZM
12/05	Nipro Corporation communique ses prévisions de résultats consolidés pour le premier semestre 2026 et l'exercice clos au 31 mars 2027	CI

Autres langues

12/05	Nipro Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2026 and Fiscal Year Ending March 31, 2027
12/05	Nipro Corporation Announces Year-End Dividend for Fiscal Year Ended March 31, 2026, Payable on June 10, 2026; Provides Second Quarter-End and Year-End Dividend Guidance for Fiscal Year Ending March 31, 2027
25/03	Nipro : Announcement of Investment by Development Bank of Japan Inc. in a U.S. Subsidiary of NIPRO
24/03	Nipro : Notice Concerning Change in Depreciation Method
18/03	Nipro : Announcement of Spryte Medical, a US Affiliate of NIPRO, First Participants Enrolled in the “INSYTE” US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment
11/03	Nipro Fixes Record Date for Fiscal 2026 Year-End Dividend
11/03	Nipro : Notice Concerning the Establishment of the Record Date for the Year-End Dividend
26/02	Nipro : Announcement of Expansion of Commercial Collaboration Between Gentuity LLC, a US Affiliate of NIPRO, and GE HealthCare
25/02	Nipro : Notice Regarding the Establishment of the Nomination and Compensation Committee
09/02	Nipro Corporation Reports Earnings Results for the Nine Months Ended December 31, 2025
04/02	Nipro : Announcement of Avantec Vascular, a US Affiliate of NIPRO, Receives FDA 510(k) clearance of DVT-Focused Thrombectomy System
24/12	Nipro Corporation Announces Establishment of Wholly Owned Subsidiary in Singapore
15/12	Nipro : Notice of Subsidiary Name Change and Transfer of Sales Organization of Vascular Division
08/12	Nipro : Investment Agreement with the GHIT Fund on the development of a new detection kit for Mpox
20/11	Nipro : Announcement of Spryte Medical, a US Affiliate of NIPRO, Receives FDA IDE Approval to Initiate "INSYTE" US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment
10/11	Nipro Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending March 31, 2026, Payable on December 10, 2025
28/10/25	Nipro : Notice Concerning Acquisition of Shares of G2/Spryte Holdco, LLC (to Make It a Subsidiary)
29/08/25	NIPRO : Strengthens Americas Presence with Trade Name Change to Nipro Americas Group
08/08/25	Nipro : Announcement of Commercial Collaboration Between Gentuity LLC, a US Affiliate of NIPRO, and GE Healthcare
27/06/25	Nipro : Notice of Organizational and Personnel Changes
26/06/25	Nipro : Announcement of Executive Personnel Changes
10/06/25	Samsung Bioepis Partners With Nipro to Commercialize Biosimilars in Japan
09/06/25	Samsung Bioepis Enters into a Strategic Partnership with NIPRO for Commercialization of Multiple Biosimilars in Japan
09/06/25	Samsung Bioepis Co., Ltd. Enters into A Strategic Partnership with NIPRO Corporation for Commercialization of Multiple Biosimilars in Japan
22/05/25	Nipro : Notice of Personnel Change